Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Nat Immunol. 2010 Feb;11(2):171-9. doi: 10.1038/ni.1827. Epub 2009 Nov 29.
STAT5 and interleukin 7 (IL-7) signaling are thought to control B lymphopoiesis by regulating the expression of key transcription factors and by activating variable (V(H)) gene segments at the immunoglobulin heavy-chain (Igh) locus. Using conditional mutagenesis to delete the gene encoding the transcription factor STAT5, we demonstrate that the development of pro-B cells was restored by transgenic expression of the prosurvival protein Bcl-2, which compensated for loss of the antiapoptotic protein Mcl-1. Expression of the genes encoding the B cell-specification factor EBF1 and the B cell-commitment protein Pax5 as well as V(H) gene recombination were normal in STAT5- or IL-7 receptor alpha-chain (IL-7Ralpha)-deficient pro-B cells rescued by Bcl-2. STAT5-expressing pro-B cells contained little or no active chromatin at most V(H) genes. In contrast, rearrangements of the immunoglobulin-kappa light-chain locus (Igk) were more abundant in STAT5- or IL-7Ralpha-deficient pro-B cells. Hence, STAT5 and IL-7 signaling control cell survival and the developmental ordering of immunoglobulin gene rearrangements by suppressing premature Igk recombination in pro-B cells.
STAT5 和白细胞介素 7(IL-7)信号被认为通过调节关键转录因子的表达并在免疫球蛋白重链(Igh)基因座上激活可变(V(H))基因片段来控制 B 淋巴细胞发生。使用条件性突变使转录因子 STAT5 的基因失活,我们证明通过过表达生存蛋白 Bcl-2 可以恢复前 B 细胞的发育,这补偿了抗凋亡蛋白 Mcl-1 的缺失。在由 Bcl-2 拯救的 STAT5 或 IL-7 受体 α 链(IL-7Rα)缺陷的前 B 细胞中,EBF1 和 Pax5 的 B 细胞特异性因子以及 B 细胞承诺蛋白的基因表达以及 V(H)基因重组均正常。STAT5 表达的前 B 细胞在大多数 V(H)基因上几乎没有或没有活性染色质。相比之下,在 STAT5 或 IL-7Rα缺陷的前 B 细胞中,免疫球蛋白 κ 轻链基因座(Igk)的重排更为丰富。因此,STAT5 和 IL-7 信号通过抑制前 B 细胞中过早的 Igk 重排来控制细胞存活和免疫球蛋白基因重排的发育顺序。